Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
B4GALNT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PKP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGIRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IFITM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930595 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGGHG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTDSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ23519 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on